The estimated Net Worth of John E Elicker is at least $7.74 Milione dollars as of 10 March 2020. Mr. Elicker owns over 18,407 units of Bristol-Myers Squibb Co stock worth over $3,649,158 and over the last 12 years he sold BMY stock worth over $4,089,253. In addition, he makes $0 as Executive Vice President of Investor Relations at Bristol-Myers Squibb Co.
John has made over 33 trades of the Bristol-Myers Squibb Co stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 18,407 units of BMY stock worth $894,396 on 10 March 2020.
The largest trade he's ever made was exercising 33,715 units of Bristol-Myers Squibb Co stock on 5 June 2013 worth over $687,449. On average, John trades about 7,534 units every 75 days since 2012. As of 10 March 2020 he still owns at least 75,101 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Mr. Elicker stock trades at the bottom of the page.
John E. Elicker serves as Executive Vice President of Investor Relations of the Company. 2012 to 2017 – Senior Vice President, Public Affairs and Investor Relations 2017 to 2019 – Senior Vice President, Corporate Affairs and Investor Relations 2019 to present – Executive Vice President, Investor Relations
John Elicker is 60, he's been the Executive Vice President of Investor Relations of Bristol-Myers Squibb Co since 2020. There are 10 older and 25 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
John's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, 430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, 10016.
Over the last 16 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius e Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: